Home
TSHA
TSHA News

Latest Taysha Gene Therapies Inc. (TSHA) News on July 26, 2024

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

21 days ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Argus Research

25 days ago

Daily – Vickers Top Buyers & Sellers for 07/02/2024

Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit

Simply Wall St.

25 days ago

Insider Buyers At Taysha Gene Therapies Sitting On US$24m Profit

MT Newswires

25 days ago

Taysha Gene Therapies Insider Bought Shares Worth $2,999,999, According to a Recent SEC Filing

MT Newswires

a month ago

BMO Initiates Taysha Gene Therapies at Outperform With $5 Price Target

MT Newswires

a month ago

Taysha Gene Therapies Prices $75 Million Offering of Shares, Pre-Funded Warrants; Shares Fall

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a month ago

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

MT Newswires

a month ago

Top Premarket Decliners

MT Newswires

a month ago

Taysha Gene Therapies Starts $75 Million Common Stock Offering

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

GlobeNewswire

a month ago

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

GlobeNewswire

a month ago

Taysha Gene Therapies Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

BioPharma Dive

a month ago

Sanofi taps Belharra for immune drug research; AstraZeneca’s new cancer drug falls short

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

GlobeNewswire

a month ago

Taysha Gene Therapies to Present Clinical Data from Both REVEAL Phase 1/2 Trials During Company-Hosted Webcast and at 2024 IRSF Rett Syndrome Scientific Meeting

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

CNW Group

2 months ago

Trip.com Reveals 2024 Trip.Best Global and Asia 100 Rankings

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

Motley Fool

2 months ago

The Company Behind Mounjaro and Zepbound Is Sponsoring Caitlin Clark. Should You Buy the Stock?

3 Capital Markets Stocks to Buy Hand Over Fist in June

Motley Fool

2 months ago

3 Capital Markets Stocks to Buy Hand Over Fist in June

3 Types of Homes To Buy During Summer 2024 To Get Rich

GOBankingRates

2 months ago

3 Types of Homes To Buy During Summer 2024 To Get Rich

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

GOBankingRates

2 months ago

4 Ways the Upper Class Handles Inflation That the Middle Class Could Learn From

Gaming laptops are being left behind

Digital Trends

2 months ago

Gaming laptops are being left behind

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

GOBankingRates

2 months ago

What a Comfortable Retirement Will Cost You in 61 of the Largest US Cities

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

GOBankingRates

2 months ago

I’m a Financial Advisor: Here Are the 6 Worst Secrets You Can Keep from Me

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

Insider Monkey

2 months ago

Is Taysha Gene Therapies, Inc. (NASDAQ:TSHA) the Best Gene Therapy Company?

GuruFocus.com

2 months ago

Taysha Gene Therapies Inc (TSHA) Q1 2024 Earnings Call Transcript Highlights: Navigating ...

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

Zacks

2 months ago

Taysha Gene Therapies, Inc. (TSHA) Reports Q1 Loss, Lags Revenue Estimates

MT Newswires

2 months ago

Taysha Gene Therapies Q1 Net Loss Narrows, Revenue Declines -- Shares Down After Hours

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

GlobeNewswire

2 months ago

Taysha Gene Therapies Reports First Quarter 2024 Financial Results and Provides Corporate Update

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

GlobeNewswire

3 months ago

Taysha Gene Therapies to Release First Quarter 2024 Financial Results and Host Conference Call and Webcast on May 14

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Zacks

3 months ago

Will Taysha Gene Therapies, Inc. (TSHA) Report Negative Q1 Earnings? What You Should Know

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

GlobeNewswire

3 months ago

Taysha Gene Therapies Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for TSHA-102 in Rett Syndrome

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

TipRanks

3 months ago

These 2 ‘Strong Buy’ Penny Stocks Could Rally to $9, Says Piper Sandler

Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher

Simply Wall St.

3 months ago

Analysts' Revenue Estimates For Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Are Surging Higher

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

The Wall Street Journal

3 months ago

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

The Wall Street Journal

3 months ago

Certain Biotech Investors Get an Early Look at Results. Is That Fair?

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

4 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts

Simply Wall St.

4 months ago

News Flash: Analysts Just Made A Notable Upgrade To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Forecasts

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations

Simply Wall St.

4 months ago

Taysha Gene Therapies Full Year 2023 Earnings: Beats Expectations

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

4 months ago

Q4 2023 Taysha Gene Therapies Inc Earnings Call

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

GlobeNewswire

4 months ago

Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19

GlobeNewswire

4 months ago

Taysha Gene Therapies to Release Full-Year 2023 Financial Results, Provide Corporate and Clinical Updates and Host Conference Call on March 19

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome

GlobeNewswire

5 months ago

Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

GlobeNewswire

5 months ago

Taysha Gene Therapies Provides Update on Deprioritized Pipeline Programs

Owning 39% shares,institutional owners seem interested in Taysha Gene Therapies, Inc. (NASDAQ:TSHA),

Simply Wall St.

5 months ago

Owning 39% shares,institutional owners seem interested in Taysha Gene Therapies, Inc. (NASDAQ:TSHA),

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

7 Micro-Cap Stocks That Could Majorly Surprise Investors

InvestorPlace

6 months ago

7 Micro-Cap Stocks That Could Majorly Surprise Investors

Unitil Schedules Fourth Quarter 2023 Earnings Release and Conference Call

GlobeNewswire

6 months ago

Unitil Schedules Fourth Quarter 2023 Earnings Release and Conference Call

GlobeNewswire

6 months ago

Diana Shipping Inc. Announces Expansion of Previously Announced Joint Venture for Offshore Wind Service Vessels

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

GlobeNewswire

6 months ago

Taysha Gene Therapies Announces Poster Presentation on TSHA-102 in Rett Syndrome at Upcoming British Paediatric Neurology Association 2024 Annual Conference

Cushman & Wakefield plc (CWK) is Benefitting from Secular Trends

Insider Monkey

6 months ago

Cushman & Wakefield plc (CWK) is Benefitting from Secular Trends

Private companies account for 54% of Betterware de México, S.A.P.I. de C.V.'s (NASDAQ:BWMX) ownership, while individual investors account for 33%

Simply Wall St.

6 months ago

Private companies account for 54% of Betterware de México, S.A.P.I. de C.V.'s (NASDAQ:BWMX) ownership, while individual investors account for 33%

The 7 Most Undervalued Growth Stocks to Buy in January

InvestorPlace

6 months ago

The 7 Most Undervalued Growth Stocks to Buy in January

3 Growth Stocks That Could Go Parabolic in 2024

Motley Fool

6 months ago

3 Growth Stocks That Could Go Parabolic in 2024

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

GlobeNewswire

7 months ago

Taysha Gene Therapies Announces First Pediatric Patient Dosed with TSHA-102 in REVEAL Phase 1/2 Pediatric Trial in Rett Syndrome

Bowman Consulting Group Ltd CFO Bruce Labovitz Sells 6,009 Shares

GuruFocus.com

7 months ago

Bowman Consulting Group Ltd CFO Bruce Labovitz Sells 6,009 Shares

Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies

PR Newswire

7 months ago

Trinity Capital Inc. Provides $40 Million Term Loan to Taysha Gene Therapies

ACNB (ACNB) Soars 8.2%: Is Further Upside Left in the Stock?

Zacks

7 months ago

ACNB (ACNB) Soars 8.2%: Is Further Upside Left in the Stock?

PR Newswire

7 months ago

JOHN HANCOCK CLOSED-END FUNDS ANNOUNCE RENEWAL OF SHARE REPURCHASE PLANS

Cognyte to Announce Third Quarter FY2024 Financial Results on December 13, 2023

Business Wire

8 months ago

Cognyte to Announce Third Quarter FY2024 Financial Results on December 13, 2023

Bank OZK (OZK) Moves 5.4% Higher: Will This Strength Last?

Zacks

8 months ago

Bank OZK (OZK) Moves 5.4% Higher: Will This Strength Last?

If You Can Only Buy One Stock, It Better Be One of These 3 Names

InvestorPlace

8 months ago

If You Can Only Buy One Stock, It Better Be One of These 3 Names

PR Newswire

8 months ago

Uber Technologies, Jabil and Builders FirstSource Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

PR Newswire

8 months ago

JOHN HANCOCK CLOSED-END FUNDS DECLARE QUARTERLY DISTRIBUTIONS

Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients

GlobeNewswire

8 months ago

Taysha Gene Therapies Announces Expanded Eligibility in REVEAL Phase 1/2 Adult Trial to Include Adolescent Rett Syndrome Patients

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China's Greater Bay Area

GlobeNewswire

8 months ago

CITIC Offshore Helicopter and Lilium partner to launch eVTOL Network in China's Greater Bay Area

Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares

Simply Wall St.

8 months ago

Insider Buying: Taysha Gene Therapies Board Observer Bought US$163k Of Shares

ParkOhio Announces Ratings Upgrade from Moody’s

Business Wire

8 months ago

ParkOhio Announces Ratings Upgrade from Moody’s

Party Time: Brokers Just Made Major Increases To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Earnings Forecasts

Simply Wall St.

8 months ago

Party Time: Brokers Just Made Major Increases To Their Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Earnings Forecasts

James River Group Holdings, Ltd. (NASDAQ:JRVR) Q3 2023 Earnings Call Transcript

Insider Monkey

8 months ago

James River Group Holdings, Ltd. (NASDAQ:JRVR) Q3 2023 Earnings Call Transcript

GuruFocus.com

9 months ago

Third Harmonic Bio Inc (THRD) Reports Q3 2023 Financial Results and Continues Progress Towards ...

GlobeNewswire

9 months ago

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

Associated Press Finance

9 months ago

Cresud: Fiscal Q1 Earnings Snapshot

Brookfield Business Partners L.P. (NYSE:BBU) Q3 2023 Earnings Call Transcript

Insider Monkey

9 months ago

Brookfield Business Partners L.P. (NYSE:BBU) Q3 2023 Earnings Call Transcript

Share on Social Networks: